Sign up USA
Proactive Investors - Run By Investors For Investors

VentriPoint Diagnostics names healthcare professional as new head of sales for North America

"Ventripoint is an impressive company with innovative products to improve patient cardiac diagnosis and care," added McPhedra
VentriPoint Diagnostics names healthcare professional as new head of sales for North America
VentriPoint has developed a suite of applications for all major heart diseases

Heart analysis firm VentriPoint Diagnostics Ltd (CVE:VPT) has hired health care industry professional David McPhedran as director of sales for North America with immediate effect.

"He has a successful track record in establishing and managing sales teams for imaging products in the North American marketplace," said Desmond Hirson, president of Ventripoint.

"Ventripoint is an impressive company with innovative products to improve patient cardiac diagnosis and care," added McPhedran.

"I have engaged numerous cardiologists across Canada and can report that they are very interested in Ventripoint's technology as it helps to address the need for affordable, accurate cardiac measurement tools."

McPhedran's  CV includes director of sales for imaging in Western Canada for Siemens Healthcare, where his team achieved sales targets of $35mln a year.

He has also worked for Becton Dickinson and Johnson & Johnson in sales and marketing.

Shares eased  1.47% to C$0.34.

View full VPT profile View Profile

VentriPoint Diagnostics Ltd. Timeline

Related Articles

couple looking at pregnancy test
November 13 2017
The proceeds from the fundraiser will be used to expand in the People's Republic and will invested in product development
scientist looking through microscope
April 11 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
1528305384_Untitled-design-(3).jpg
June 06 2018
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use